ONDAMED Teleconference Calls

ONDAMED Teleconference Info Network

ONDAMED is approved as a Non-Invasive Secondary Therapeutic Device by the F.D.A. Institutional Review Board for treatment of various disorders which alleviates pain, discomfort or general malaise.

Practitioners around the world are being trained not only by dedicated men and women of ONDAMED, INC., but by leading engineers, scientists, doctors and practitioners of all types who for decades have dedicated their lives in researching, documenting, studying, and teaching "Energy Medicine". Through these recorded and archived Conference Calls, practitioners have at their fingertips tremendous resources above formal classroom settings conducted by ONDAMED, INC. A reliable and credible resource for ongoing education by professional practitioners as well a learning or research site to learn about Energy Medicine and the ONDAMED Biofeedback Device technology.

October 2007 Topic — Case Studies with Dr. Shari Lieberman

Guest Speakers: Dr. Shari Lieberman, PhD, Rolf Binder, and Dr. Wolf-Dieter Kessler, MD

The very first of the Teleconference Calls series was kicked off by Dr. Shari Lieberman who shares 3 case studies on this conference call: Multiple Sclerosis (MS), Planter Fasciatis, and Traumatic Brain Injury. These audios are extremely impressive for not only do we hear from a leading, hugely recognized and credible scientific researcher but from patient and doctors who treated these patients. This is an extremely credible and educational series of audios which focuses on the ONDAMED's efficacy as well as the science behind the successes of doctors and practitioners with their patients.

To Download Audio

To download any audio, click the "Arrow" of the recorded audio of your choice.

To the right is the media player. Each number corresponds to each section of the conference call listed below. Simply click on the section you wish to listen to or place your cursor over the number and click on the arrow to launch the download option.

01:	Silvia Binder & Dr. Shari Lieberman, PhD, CNS, FACN: Case Studies – Introduction
02:	Dr. Shari Lieberman – Case Study: Multiple Sclerosis
03:	Multiple Sclerosis Patient – Actual MS Patient Fields Questions
04:	Dr. Kessler & MS Patient – Questions & Discussions between Dr. Kessler and MS Patient
05:	Dr. Shari Lieberman & Dr. James Fogarty – Case Study: Planter Fasciatis with Discussions between Dr. Lieberman & Dr. Fogarty, the Patient's Physician
06:	Dr. James Fogarty – Question Asked of Dr. Fogarty: What Programs were Used in Treatment
07:	Dr. James Fogarty – Question Asked of Dr. Fogarty: Other Therapies Used
08:	Dr. Shari Lieberman, Dr. James Fogarty & Dr. Kessler – Planter Fasciatis & Pain Management Discussions
09:	Dr. Kessler – Question Asked on Osteoporosis & Bone Metabolism
10:	Dr. Shari Lieberman & Dr. Elaina J. – Case Study: Traumatic Brain Injury with Discussions between Dr. Lieberman & Dr. Elaina J., the Patient's Physician
11:	Dr. Kessler, Silvia Binder & Dr. Elaina J. – Programs used for Traumatic Brain Injury & Additional Information
12:	Dr. Elaina J., Silvia Binder – Questions on Medication & Follow-up Discussion
13:	Dr. Kessler – Research Information on Pain Managemen
14:	Dr. Kessler, Silvia Binder & Rolf Binder – Discussions on Frequency Use and Efficacy
15:	Dr. Kessler, Silvia Binder, & Dr. Fogarty – Response of Medication with the use of the Ondamed
16:	Dr. Kessler, Silvia Binder, Rolf Binder & Dr. Fogarty – Understanding Energy Medicine and the Healing Process
17:	font-family: verdana,geneva">Dr. Kessler & Silvia Binder – Additional Questions on Dementia & Leukemia
18:	Silvia Binder – The Best Place to Start, and Conference Call Wrap-up

DISCLAIMER: The information provided herein is for Educational Purposes Only and has not been designed to diagnose, treat, mitigate, prevent or cure any health conditions.
Please consult a qualified Health Care Professional to diagnose your health conditions and avoid self-diagnosis.
The U.S. Food and Drug Administration has not evaluated statements about these health topics or any suggested product compositions.